The biotechnology industry has almost limitless growth potential. With rapid technological advancements, many biotech companies are diving into previously unexplored areas of medical science. Now, artificial intelligence (AI) is the cherry on top, allowing businesses to use its capabilities to accelerate drug discovery, optimize clinical trials, personalize medicine, and streamline operations.
One biotech company with tremendous long-term potential is Alphatec Holdings (ATEC), a key player in the spine surgery market. The company’s innovative solutions for spine surgery have caught analysts' attention.
